Key result
Type 2 diabetes mellitus was associated with higher circulating betatrophin levels compared to nondiabetic controls.
Why the study?
Are circulating betatrophin levels higher in patients with type 2 diabetes compared to nondiabetic adults?
Meta-Analysis
Are circulating betatrophin levels higher in patients with type 2 diabetes compared to nondiabetic adults?
Circulating betatrophin levels are significantly elevated in nonobese patients with type 2 diabetes compared to nondiabetic controls, but this difference is not observed in obese individuals.
Answers are grounded in this paper and cite their sources.
Elevated betatrophin may mark T2DM risk; confirms association in meta-analysis but leaves open causality and utility.
OBJECTIVE: To investigate the association between circulating betatrophin level and type 2 diabetes mellitus (T2DM) in human. METHODS: A comprehensive literature search was performed in PubMed and Embase databases to identify eligible studies assessing the circulating levels of betatrophin in both T2DM patients and nondiabetic adults. RESULTS: A total of nine eligible studies with twelve comparisons were included for the final meta-analysis. Circulating betatrophin levels in T2DM patients were higher than those in the nondiabetic controls (random-effect SMD 0.53; 95% CI 0.13 to 0.94; P = 0.010). In the subgroup of nonobese population but not the obese population, the overall betatrophin level in T2DM patients was much higher than that in the nondiabetic controls (nonobese: random-effect SMD, 0.82; 95% CI 0.42 to 1.21; P < 0.001; obese: random-effect SMD, -0.39; 95% CI, -0.95 to 0.18; P = 0.18). Metaregression indicated that body mass index of T2DM patients was associated with mean difference of betatrophin level between T2DM and nondiabetic adults (slope, -578.8; t = -2.7; P = 0.02). CONCLUSION: Based on the findings of our meta-analysis, circulating betatrophin level of T2DM patients is higher than that of nondiabetic adults in the nonobese population, but not in the obese population.
No takes yet. Share an insight, caveat, or question.
Li et al. (2015) conducted a meta-analysis in Type 2 diabetes mellitus. Type 2 diabetes mellitus vs. Nondiabetic adults was evaluated on Circulating betatrophin level (SMD 0.53, 95% CI 0.13 to 0.94, p=0.010). Type 2 diabetes mellitus was associated with higher circulating betatrophin levels compared to nondiabetic controls.
Synapse has enriched 10 related papers. Consider them for comparative context: